The purpose of this study was to provide a comprehensive review of the literature relating to electron beam angiography (EBA), magnetic resonance angiography, and spiral computed tomography, currently the three most promising noninvasive methods to visualize obstructions in the coronary tree. BACKGROUND Given the high costs and invasiveness of coronary angiography, there is increased interest in noninvasive coronary angiography, which has made great strides to become a clinically useful tool to augment conventional coronary angiography (CCA).
Over the past decade, great strides have been made in cardiac imaging. The ability to visualize the lumen of the coronary artery has been at the forefront of these advances. Selective cardiac catheterization, the reference standard for visualization of coronary artery stenoses, is an invasive procedure with a significant cost and small-procedurerelated morbidity and mortality. An alternative, less expensive, and noninvasive test for use as a diagnostic tool before possible intervention could have a major impact on health care practice and cost containment. Noninvasive coronary angiography, owing to rapid coronary motion, limited arterial size, and tortuous course, has been very challenging. We review here the benefits, risks, and costs of invasive angiography to that of the three noninvasive methods with the greatest clinical experience, namely electron beam tomography (EBT), multi-row-detector spiral computed tomography (MDCT), and magnetic resonance imaging (MRI).
ANGIOGRAPHY
Coronary angiography remains the standard for assessment of anatomic coronary disease (1) . The limitations of this procedure include the risks (arterial puncture, iodinated contrast, and radiation), the need for multiple staff members including a nurse, physician, and technologists, and the costs incurred during the procedure and the ensuing observational period. Given these potential complications, the physician must make reasoned decisions on its use based on the anticipated clinical benefit versus the risks and costs of the procedure. Risk and utilization of invasive angiography. The procedure is associated with a small but definable risk. The 1999 Joint Coronary Angiography Guidelines report a total risk of all major complications (including mortality) from coronary angiography to be just Ͻ2% (2) . In 1993, some 1.8 million cardiac catheterization procedures were performed (3) . From 1979 to 2000, the number of cardiac catheterizations increased 341%. The estimated utilization of cardiac catheterizations (inpatient and outpatient) was Ͼ2 million in the year 2000 (3) . Costs. The 1992 mean charge for cardiac catheterization for inpatients younger than 65 years without a diagnosis of acute myocardial infarction was $10,880, varying by state from a low of $6,400 in Maryland to $17,600 in California (4). These values included all costs associated with the procedure, including ventriculography, observation, and physician charges. The physician fee made up 18% of the total, averaging $2,000 and varying from $1,300 in South Carolina to $2,550 in California (5) . The average total cost for patients hospitalized for diagnostic cardiac catheterization increased from $11,232 in 1993 to $16,838 in 2000 (6) . It must be noted that there is often a large disparity between charged and collected sums; however, the costs of invasive angiography remain high. Currently, charges for noninvasive angiography range from $1,500 to $2,450 (including physician interpretation charges) in different medical centers. Research on the cost-effectiveness of noninvasive coronary angiography is needed before the optimal use of this procedure in a wide range of clinical circumstances can be determined. Current uses. Despite cost, inconvenience, and morbidity, coronary angiography is the only method currently available for defining the details of the entire coronary endoluminal vascular anatomy, and it provides the reference standard against which other tests are compared (7) . The ability to detect obstructive and nonobstructive disease is of paramount importance for guiding therapy. Although coronary lesions that reduce luminal diameter Ͻ50% are considered hemodynamically insignificant, they are not clinically benign. These lesions may progress either acutely or chronically, and patients with nonsignificant obstructions have significantly more cardiovascular events during follow-up than those with truly normal coronary angiograms (8) . Furthermore, cardiac angiography can also define multiple cardiac diseases (cardiomyopathy, heart failure, valve disease, and endothelial dysfunction). Potential role of noninvasive angiogram. Although conventional coronary angiography (CCA) remains the standard of reference for determining the severity of stenosis resulting from atherosclerosis in the coronary arteries, it is unfortunate that at least 20% of the clinically indicated diagnostic CCA procedures performed each year reveal no evidence of obstructive coronary artery disease (CAD), and therefore do not lead to further interventional procedures (9) . This problem may be twice as significant in women. A recent report of 9,238 angiograms from five community hospitals demonstrated that 40.4% of women referred for angiography were found to have nonsignificant disease, nearly twice that of men (10) . Because most of the risk of conventional angiography including stroke, MI, infection, and bleeding, revolves around the need for arterial access, noninvasive methods, approached by intravenous administration of contrast (or no contrast at all), eliminate most of the risk associated with the procedure, including postprocedural observation periods, MI, stroke, bleeding, arterial infection, and vessel dissection. Difficulties of noninvasive angiography. Fluoroscopy, the method used to visualize the coronary artery lumen during angiography, has high temporal resolution, but low contrast resolution. Thus, it requires direct enhancement of the coronary artery blood pool to allow visualization of the lumen. Noninvasive angiography, without direct injection of contrast into the artery, utilizes increased spatial resolution to overcome the problems of loss of superb contrast enhancement and temporal resolution. Furthermore, rapid motion of the coronary arteries, complex and tortuous anatomy, as well as the small size of the vessels, all make noninvasive imaging challenging. All three techniques rely upon three-dimensional (3D) reconstruction to assist with visualization. The computed tomography (CT) techniques (EBT and MDCT) rely upon superior spatial resolution and a venous contrast injection. The venous contrast does not provide as robust an enhancement of the coronary arteries as does direct arterial injection, because the contrast is diluted by mixing with the blood pool. Magnetic resonance imaging often utilizes gadolinium, a noniodinated contrast agent, to increase the identification of the lumen.
ELECTRON BEAM TOMOGRAPHY
Electron beam tomography with electrocardiographic (ECG) triggering has been used for detecting and quantifying coronary artery calcifications (CAC) for more than 15 years (11, 12) ; EBT is established as the "gold standard" for CAC detection (13) . Though CAC scores correlate well with the total atherosclerotic burden (14, 15) and strongly predict future cardiac events (16, 17) , the amount of CAC does not correlate well with the stenosis severity of a given lesion (18) . Although high calcium scores impart an approximate 10-fold increased risk, they do not always impart a tight stenosis (Table 1) (19) . Moreover, because plaque burden itself is dangerous regardless of stenosis severity, use of calcium scanning for predicting the need for angioplasty or bypass surgery is limited.
Electron beam tomography appears well suited for imaging of the coronary artery. It has a unique combination of high temporal resolution (100 ms/slice) and spatial resolutions (0.35 ϫ 0.35 ϫ 1.5 mm) (13), allowing visualization of small lesions. Furthermore, ECG triggering allows image
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3D
ϭ three-dimensional CABG ϭ coronary artery bypass graft CAC ϭ coronary artery calcifications CAD ϭ coronary artery disease CCA ϭ conventional coronary angiography CT ϭ computed tomography EBA ϭ electron-beam angiography EBT ϭ electron-beam tomography ECG ϭ electrocardiographic HR ϭ heart rate MDCT ϭ multi-row-detector spiral computed tomography MRA ϭ magnetic resonance angiography MRI ϭ magnetic resonance imaging acquisition during the slow portion of coronary motion (diastole) (20, 21) . Contrast-enhanced electron beam angiography (EBA) is an emerging technology with the potential for obtaining essentially noninvasive coronary arteriograms ( Figs. 1 and 2 ). Recent studies have reported contrast-enhanced, ECG-triggered, 3D EBA for detecting and grading coronary stenosis (22) (23) (24) (25) (26) (27) (28) .
Coronary artery EBA, a noninvasive diagnostic procedure for demonstrating coronary artery anatomy, was first introduced in 1995 (22) . Two studies (28, 29) confirmed that coronary EBA with 3D techniques could reveal the lumen of long segments of the major coronary arteries with high correlation to conventional selective CCA (r ϭ 0.83) (29) . In evaluating this modality, comparison to CCA was performed so as to assess the accuracy in which it can detect a significant stenosis (Ͼ50% luminal diameter). This modality has been demonstrated to identify significant coronary lumen narrowing (Ͼ50% stenosis) with the sensitivity of 74% to 92%, specificity of 79% to 100%, and accuracy of 81.2% to 93.4% (Table 2 ). Summary data demonstrate an overall sensitivity of 87% and specificity of 91% for the 583 patients reported in these studies. The EBT noninvasive angiography had a success rate of 70% to 93% in the ability to correctly interpret all three coronary arteries per patient (26 -28) . Also, interobserver reproducibility was found to be high (0.74 to 0.90 by Cohen's kappa statistic) (26, 27) .
There is fair uniformity and imaging standards among EBA studies. The imaging procedure used by the above studies are all performed with similar imaging techniques. The studies were performed with a C-100 or C-150XLP electron beam CT scanner (Imatron, South San Francisco, California). The ECG triggering is employed so that each image is obtained at the same point in diastole. Iodinated contrast is administered through an antecubital or jugular vein with an injection rate of 4 ml/s and total volume of 120 to 160 ml. Forty to 50 images are obtained over a single breath-hold, usually over 25 to 40 s. This entire protocol is performed within 15 min. The test is easy to perform, and interpretation can be made in minutes.
Limitations of EBT.
The EBA studies had a technical success rate of 85% to 100%, and 8% to 25% of coronary arteries were nonassessable (Table 2) . Impaired image quality, due to multiple image artifacts including coronary artery motion and breathing artifacts, limited EBA clinical use.
One major limitation of all noninvasive imaging is dense calcifications in the coronary tree, with investigators citing scores Ͼ500 or Ͼ1,000 as problematic (26, 27) . Because the calcification score is not always known in advance of noninvasive angiography, some cases will prove nondiagnostic. In EBA studies, distal arteries are not as well visualized as the proximal segments. This is most likely due to the greater motion artifacts from cardiac pulsation and the partial volume effect (due to small vessel diameters) in distal epicardial vessels, as compared with the proximal segments (24, 26, 30) . Another limitation of all noninvasive angiography is the relative inability to visualize collaterals. The main determinant of false positive results for diagnosing Ն50% coronary luminal stenosis was small vessel size (22, 30) , and the diameter of stenotic segments tends to be underestimated by EBA (24) . Some progress has been made over the last year to improve image quality and interpretation of the EBA. Recent studies revealed that the ECG triggering at 80% of the R-R interval (late diastole) used in most earlier studies might not be optimal for imaging of the coronary segments near the right or left atria, because atrial contraction during end-diastole causes rapid movement of the base of the heart (26, 31) . It has been recently demonstrated that there is less coronary motion at 40% of the R-R interval (early diastole or end-systole) (32, 33) , which might significantly improve imaging. Improvements including more reliable ECG gating, use of different ECG triggers (40% instead of 80% of the R-R interval), and greater experience with this technique will continue to improve accuracy. Hardware improvements in the EBT scanner should also lead to higher accuracy. An available high-resolution detector system improves the spatial resolution by almost 40%, thus enabling improved imaging performance for future studies (34) . Furthermore, the new e -speed scanner (GE-Imatron, South San Francisco, California) allows for image acquisition in 50 ms, as well as obtaining dual imaging and allowing for thinner slices with less cardiac motion. Currently, the high negative predictive values (95% to 98%) have demonstrated the ability of this tool to effectively "rule out" the presence of obstructive CAD, thus helping the clinician to potentially utilize this tool to determine the need for medical versus revascularization therapy. Electron beam angiography after revascularization. The EBA is a promising tool in the follow-up after coronary interventions, with the potential to replace some invasive catheterization procedures (Figs. 3 to 5) (35) . The utilization of EBA to detect the patency of coronary artery bypass graft (CABG) has been reported as early as 1986 (36). Saphenous vein grafts, which are generally of large caliber and have little cardiac motion, are especially well suited for noninvasive imaging with EBA (Figs. 4 and 5) . Flow studies (sequential image acquisition to determine the rate of contrast enhancement at a particular point in the anatomy) demonstrate graft patency with sensitivities of 93% to 96% and specificities of 86% to 100% (35, (37) (38) (39) (40) . Using 3D visualization in patients post-CABG, graft stenosis and patency can be determined. Recent studies demonstrated a sensitivity of 92% to 100% and specificity of 91% to 100% for establishing patency (and lack of significant obstructive disease) of saphenous vein grafts as compared with CCA (43) . However, even with intracoronary stents, restenosis (closure) of the site of angioplasty is still the greatest risk, which can lead to both 
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Noninvasive Coronary Angiography MI and death. Chest pain after stenting or angioplasty often requires visualization of the site of angioplasty to assess for early closure. A noninvasive method to visualize the site of angioplasty could potentially be used for less typical presentations of acute closure (no typical angina or ECG changes suggestive of ischemia). Use of EBA has been shown to permit imaging of the coronary arteries and detection of high-grade restenosis after coronary angioplasty (Fig. 3) . Achenbach et al. (44) reported 50 cases in which coronary angioplasty was performed without coronary stent implantation. The sensitivity and specificity of EBA was 94% and 82%, respectively, to detect severe stenosis (Ն70% stenosis). Intracoronary stenting is now increasingly used to decrease the restenosis rate of coronary angioplasty (45) and to avoid emergent complications, such as acute thrombus, coronary artery dissection, and even emergent CABG (46) . The ability to visualize the coronary lumen through the metal of the stent poses severe problems for EBA, MDCT, and magnetic resonance angiography (MRA). The widespread utilization of metal stents during revascularization procedures provides a major limitation for the clinical application of these techniques. One potential solution to the problem of visualizing the lumen within the stented region is to utilize EBA flow studies to evaluate contrast enhancement distal to the stent for patency (47-50). Pump et al. (50) reported a sensitivity of 78% (18 of 23 stenoses detected) and specificity of 98% (189 of 193 stents correctly judged to be free of stenosis) for the detection of significant in-stent restenosis by EBA flow measurements. Current clinical uses. The most common clinical application of EBA is to evaluate patients with symptoms post-CABG surgery and coronary angioplasty evaluation, assessment of congenital heart disease and coronary anomalies (51), and measurement of wall motion, myocardial mass, and right and left ejection fractions (52, 53) . Given the high negative predictive values, use in patients with lower probabilities of obstructive disease will potentially allow physicians to exclude obstructive CAD in proximal and midvessels. As compared with CCA, use of EBA is minimally invasive, has an extremely short acquisition time, and was a markedly lower radiation dose (54) . Patients unable to breath-hold for 25 s, those with significant arrhythmias, and morbidly obese patients are poor candidates for EBA. The Food and Drug Administration has approved EBT for use in noninvasive coronary angiography. The newest model of EBT is the e-speed scanner, allowing for 50-ms image acquisition and multidetector imaging. This new device, currently available only in limited centers, will shorten breath-hold, lower radiation, and decrease motion artifacts owing to faster image acquisition.
SPIRAL COMPUTED TOMOGRAPHY
The "need for speed" is essential in obtaining virtually motion-free images. The significantly improved temporal and spatial resolution of MDCT scanners opens up new possibilities for cardiac imaging. Because of high in-plane resolution and thin-slice collimation (up to 1.0 mm), high-quality images can be obtained (Fig. 6) . However, as the mechanical detector head must rotate around the patient, no current CT can obtain a full rotation in less than 400 ms, too slow to allow for motion-free imaging of the coronary arteries (55, 56) . Multislice CT has the new capability of obtaining multiple images simultaneously, continuously imaging, obtaining 4, 8, or even 16 slices at once. Each slice is still obtained with the limited gantry rotation speed, but simultaneous imaging allows for thinner slices and shorter scanning protocols (decreased need for long breath-holding by patient). The newer MDCT equipment now rotates at 420 ms, with up to 16 detectors for cardiac imaging.
Through the use of simultaneously recorded ECG data, images from the MDCT can be reconstructed at any point in the cardiac cycle. The MDCT obtains continuous volume imaging of the heart (up to 400 images of the coronary tree are obtained), then utilizes a fraction of the obtained data for image reconstruction. Retrospective triggering, acquiring partial data on each scan, may allow shorter acquisition times, but require sophisticated postprocessing algorithms to reduce motion artifacts (56) . Several studies are listed in Table 3 . Achenbach et al. (57) reported the applicability and image quality of MDCT and EBT on 30 patients without coronary stenoses. This demonstrated that coronary arteries could be visualized over long segments. On average, 73% of the proximal and midsegments could be visualized free of motion artifacts with MDCT (92% with EBT, p Ͻ 0.001), and coronary diameters showed close correlation with both techniques to quantitative coronary angiography (r ϭ 0.86).
Multiple studies with four-slice MDCT have been reported. Most studies reported a diminished overall sensitivity. One MDCT study demonstrated an overall sensitivity of 58%, which varied widely from vessel to vessel (58) . The left main coronary artery had a sensitivity of 100%, whereas stenoses in the circumflex had a sensitivity of only 44%. Most studies demonstrate approximately 70% of vessels available for analysis (Table 2) . Another study had 68% of vessels interpretable, and 32 of 58 high-grade stenoses were detected (sensitivity 58%) (59) . However, all four major coronary arteries could be evaluated in only 30% of patients. The investigators note that "its clinical use may presently be limited due to degraded image quality in a substantial number of cases, mainly due to rapid coronary motion." Giesler et al. (60) reported 115 of 400 (29%) coronary arteries uninterpretable, and in only 39% of patients were all coronary arteries assessable by MDCT. Overall, 51 (49%) of 104 stenoses were revealed on MDCT. Most studies demonstrate a significant heart rate (HR) interaction. One study showed that overall sensitivity for stenosis detection decreased from 62% (HR Ͻ70 beats/min) to 33% (HR Ͼ70 beats/min) (60), whereas sensitivity dropped in another study from 82% (mean HR 55.8 beats/min) to 32% (mean HR 81.7 beats/min) (61, 62) . In another study (63) , the correct clinical diagnosis could be obtained in only 36% of patients (Table 3) . Limitations of MDCT. Because radiation is continuously applied while only a fraction of the acquired data is utilized, high radiation doses (doses of 6 to 10 mSv/study) limit the clinical applicability of this modality (54, 64) . In female patients, the effective radiation dose is another 25% higher than in male patients (WinDose 2.0a, Scanditronix Wellhofer, Bartlett, Tennessee), raising the mean dose from 8 mSv in men to 10 mSv per study in women (65) . These radiation doses are two to five times higher than can be expected for conventional angiography, and 5-to 10-fold higher than doses obtained during EBA (1 to 1.7 mSv) (2, 64, 67) . In two studies of radiation dose, EBA yielded doses of 1.5 to 2.0 mSv, MDCT angiography 8.1 to 13 mSv, and coronary angiography 2.1 to 2.3 mSv (66), whereas another study reported EBA doses of 1.1 mSv and MDCT doses of 9.3 to 11.3 mSv (67). The radiation dose using the new 16-level detectors has not yet been reported. Current clinical uses. The use of the new 16-slice MDCT scanners (420-ms rotation time, 12 ϫ 0.75 mm collimation) allows for faster and thinner imaging than the four-slice scanners. Two studies have been reported, each with improved accuracy as compared with prior reports with fourslice scanners. These studies reported sensitivity of 73% to 95% and specificity of 86% to 93% (68, 69) . Both studies concluded the MDCT with beta-blocker premedication permits detection of CAD with high accuracy. Reduced radiation doses and improved rotation times will make MDCT a more clinically useful modality. 
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Magnetic resonance angiography. The MRA provides excellent soft tissue contrast, has inherent 3D capabilities, and allows acquisition in any anatomic plane. Furthermore, MRA does not expose the patient to radiation, nor iodinated contrast, making this the safest of the current noninvasive modalities, excluding those patients with pacemakers, implantable defibrillators, or recent stent placement. An MRA of the coronary arteries became possible in 1991 with the development of a new group of fast magnetic resonance imaging (MRI) sequences (70, 71) . The new MRI techniques may also allow quantification of velocity and flow in coronary arteries; also, MRI has proved successful in producing angiograms of peripheral vascular anatomy and abnormalities (72) . Recent advances in fast magnetic resonance imaging (MRI) have allowed for compensation of coronary and respiratory motion (73) (74) (75) (76) . However, limitations in spatial and temporal resolution make visualizing coronary artery lumens more difficult (Fig. 7-9 ). All coronary MRA techniques use ECG-triggering. First-generation breath-hold techniques acquire one twodimensional image per breath-hold; however, the clinical usefulness was severely limited (77) (78) (79) (80) (81) (82) . The secondgeneration techniques use respiratory gating or triggering and are referred to as "non-breath-holding" or "freebreathing" techniques, as they do not require breathholding during image acquisition (83, 84) . Third-generation techniques that allow 3D volume acquisitions in a single breath-hold, in combination with real-time interactive slice positioning, appear very promising. Real-time slice positioning, and higher-resolution acquisition schemes, such as spiral MRA, can further improve and facilitate the use of these coronary MRA techniques (85) (86) (87) (88) (89) (90) (91) (92) (93) (94) (95) (96) (Figs. 7 and 8 ).
The newest versions will allow 3D volume acquisitions in one breath-hold and/or real-time interactive slice positioning (Fig. 9) (97-101) . In addition, the use of magnetic resonance contrast agents appears to further improve some techniques (102, 103) .
TWO-DIMENSIONAL MAGNETIC RESONANCE CORONARY ANGIOGRAPHY (FIRST-AND SECOND-GENERATION TECH-NIQUES).
The breath-hold two-dimensional technique represented the first attempt at high-resolution imaging of the coronary arteries (77) . A breath-hold lasting 16 heartbeats could produce a single image (Table 4) . However, multiple breath-holds were necessary to cover all parts of the coronary artery tree, and the exact reproduction of the level of inspiration required extremely good collaboration of the patient and caused problems in up to 44% of all subjects. Other limitations of the technique included long study times, difficulties in distinguishing veins or pericardial structures from coronary arteries, poor visualization of the left main coronary artery, and impaired image quality due to ghosting, ringing, and blurring (79) . Although an early study with MRA yielded favorable results (78) , multiple subsequent studies could not reproduce the promising results obtained in these initial reports (73,79 -82) (Table 4) . (90 -93) . Accuracy varies widely from study to study (sensitivity: 38% to 83%, specificity: 57% to 95%) even when the exams of subjects with poor image quality are excluded (Table 4) . A recent multicenter study of 109 patients using the free-breathing technique revealed a total of 636 of 759 proximal and middle segments of coronary arteries (84%) were interpretable on MRA (104) . In these segments, 78 (83%) of 94 clinically significant lesions (those with a Ͼ50% reduction) were detected by MRA. Overall, coronary MRA had an accuracy of 72% (95% confidence interval, 63% to 81%) in diagnosing CAD (104) . Summary data reveal a sensitivity of 77% and specificity of 71% in the 387 patients reported in these studies. not an alternative to conventional CCA in all cases (Table  6 ). All three, however, are currently used clinically in certain centers. Selective use might prove both cost-effective and provide a safer, less-invasive method for patients. These noninvasive techniques have potential capabilities of assessing perfusion and coronary flow in addition to coronary anatomy, and thus may provide a comprehensive cardiac evaluation. Successful development of a noninvasive angiogram with consistently high sensitivity and specificity for obstructive CAD would greatly reduce the cost and also the morbidity and mortality currently associated with conventional coronary arteriography. The replacement of some of these invasive procedures by noninvasive means would be very desirable. Some potential uses include: following the nondiagnostic stress test; for those persons with intermediate likelihood of CAD (where the step to coronary angiography might be premature); for symptomatic persons postcoronary angioplasty and possibly post-stent; evaluating graft patency post-CABG, and for early detection of obstructive CAD in the high-risk individual. Given the current utility of these techniques, we can expect a rapid growth in both the knowledge and experience with noninvasive angiography, leading to a much wider clinical use of these new techniques in visualizing the coronary lumens to evaluate obstructive coronary disease. 
THE 3D RESPIRATORY GATED MAGNETIC RESONANCE COR-ONARY ANGIOGRAPHY TECHNIQUES (THIRD-GENERATION TECHNIQUES
